 Evofem Biosciences Inc NASDAQ: EVFM shares are trading lower by 59.76 at 0.44 after the company announced the pricing of a roughly 26.6 million public offering. Evofem says the company intends to use the net proceeds from the offering for the continuation of commercialization activities. 